SHATTUCK LABS, INC.

STTK
Delayed Quote. Delayed  - 11/27 01:00:00 pm
34.48USD -2.68%
Prev.35.4300
Open35.7800
High36.9700
Low33.2350
Volume167 879
Latest news
2d ago
2d ago
11/13
11/13
Chart SHATTUCK LABS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance35,035,032,6
Spread/Res.-1,5%-1,5%5,8%
Spread/Supp.39%81%78%
Support24,919,019,4
Financials
Sales 2020 10,00 M - -
Net income 2020 - - -
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 1 478 M 1 478 M -
Capi. / Sales 2020 148x
Capi. / Sales 2021 190x
Nbr of Employees 57
Free-Float 70,0%
Company
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of dual-sided fusion proteins. The Company has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
No events available

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 3
Average target price 35,00 $
Last Close Price 34,48 $
Spread / Highest target 4,41%
Spread / Average Target 1,51%
Spread / Lowest Target -1,39%